Harvard Researchers Develop Super-Repellent Coating for Medical Implants

Image Credit: Harvard’s Wyss Institute

An innovative surface coating has been developed for medical implants using FDA-approved materials by a Harvard research team

This new solution has the potential to address bacterial infection and blood clotting, which are the two major problems currently faced by medical devices.

The new coating solution not only delayed the formation of biofilms but was also repellent to blood on over 20 medically relevant substrates made of metal and glass.

The researchers also tested the coating material by applying it to medical-grade tubing and catheters to be implanted in large blood vessels of pigs. The use of the coating material prevented blood clotting for eight hours and hence there was no need for blood thinners such as heparin.

The research team took inspiration from Slippery Liquid-Infused Porous Surfaces or SLIPs, a breakthrough surface technology created by one of the researchers, Joanna Aizenberg.

The application of SLIPS imparts repellency to any material. The presence of a liquid layer on SLIPS serves as a barrier to any substance such as blood, crude oil or ice.

In this study, the scientists took advantage of the inherent roughness of a medical device’s chemically modified surface. They created a super-repellent coating capable of adhering to prevailing medical devices.

The two-step surface-coating process involves chemically bonding a perfluorocarbon monolayer, followed by the addition of a liquid perfluorocarbon layer that is broadly used in medicine for applications such as eye surgery, blood substitution and liquid ventilation for new-born babies with breathing difficulties.

The researchers named this combination a Tethered-Liquid Perfluorocarbon surface or TLP.

During testing, a TLP-coated surface also outperformed a gecko in terms of adhesive strength. So far, the researchers have only tested the coating material on medical implants such as perfusion tubing and catheters which use relatively simple configurations.

The team at Harvard aim to test the coating material on more intricate systems such as ECMO and dialysis machines. The Nature Biotechnology journal has reported the study results.

Alexander Chilton

Written by

Alexander Chilton

Alexander has a BSc in Physics from the University of Sheffield. After graduating, he spent two years working in Sheffield for a large UK-based law firm, before relocating back to the North West and joining the editorial team at AZoNetwork. Alexander is particularly interested in the history and philosophy of science, as well as science communication. Outside of work, Alexander can often be found at gigs, record shopping or watching Crewe Alexandra trying to avoid relegation to League Two.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Chilton, Alexander. (2014, October 14). Harvard Researchers Develop Super-Repellent Coating for Medical Implants. AZoM. Retrieved on November 22, 2024 from https://www.azom.com/news.aspx?newsID=42626.

  • MLA

    Chilton, Alexander. "Harvard Researchers Develop Super-Repellent Coating for Medical Implants". AZoM. 22 November 2024. <https://www.azom.com/news.aspx?newsID=42626>.

  • Chicago

    Chilton, Alexander. "Harvard Researchers Develop Super-Repellent Coating for Medical Implants". AZoM. https://www.azom.com/news.aspx?newsID=42626. (accessed November 22, 2024).

  • Harvard

    Chilton, Alexander. 2014. Harvard Researchers Develop Super-Repellent Coating for Medical Implants. AZoM, viewed 22 November 2024, https://www.azom.com/news.aspx?newsID=42626.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.